Amrize Ltd (NYSE:AMRZ – Get Free Report) insider Stephen Clark bought 5,260 shares of Amrize stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $47.31 per share, with a total value of $248,850.60. Following the completion of the transaction, the insider directly owned 10,637 shares in the company, valued at approximately $503,236.47. This trade represents a 97.82% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink.
Amrize Stock Performance
Shares of NYSE:AMRZ traded up $0.28 during mid-day trading on Thursday, reaching $46.65. The company had a trading volume of 1,261,074 shares, compared to its average volume of 3,206,131. The company has a current ratio of 1.40, a quick ratio of 0.89 and a debt-to-equity ratio of 0.38. The firm has a market cap of $25.80 billion, a price-to-earnings ratio of 21.52, a PEG ratio of 1.02 and a beta of 0.11. The company’s 50-day moving average price is $51.50 and its 200-day moving average price is $54.58. Amrize Ltd has a one year low of $46.03 and a one year high of $65.94.
Amrize (NYSE:AMRZ – Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.88 EPS for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.17%. The firm had revenue of $3.50 billion during the quarter. As a group, equities research analysts anticipate that Amrize Ltd will post 2.72 EPS for the current fiscal year.
Amrize Announces Dividend
Analyst Ratings Changes
A number of equities research analysts recently issued reports on the company. Citigroup lowered their price objective on Amrize from $66.00 to $58.00 and set a “buy” rating on the stock in a research note on Tuesday. Truist Financial reiterated a “hold” rating and issued a $48.00 target price (down from $65.00) on shares of Amrize in a research note on Tuesday, July 7th. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research report on Friday, June 26th. Morgan Stanley set a $63.00 price target on shares of Amrize and gave the company an “overweight” rating in a research note on Monday, June 22nd. Finally, Weiss Ratings downgraded shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, five have issued a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $60.57.
Read Our Latest Research Report on AMRZ
Institutional Trading of Amrize
Institutional investors have recently added to or reduced their stakes in the stock. MCF Advisors LLC purchased a new position in Amrize during the fourth quarter valued at approximately $27,000. Basepoint Wealth LLC purchased a new stake in Amrize in the 4th quarter worth approximately $33,000. Laurel Wealth Advisors LLC bought a new position in Amrize in the 4th quarter valued at $34,000. Itau Unibanco Holding S.A. boosted its holdings in Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after purchasing an additional 450 shares during the period. Finally, US Bancorp DE purchased a new position in shares of Amrize during the 3rd quarter valued at $38,000.
Amrize Company Profile
Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.
Recommended Stories
- Five stocks we like better than Amrize
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
- Lumentum Just Delivered the AI Growth Investors Wanted
- Ryman Checks Into a $1.38B Hospitality Upgrade
- Axos Financial Keeps Proving the Digital Banking Model Works
Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.
